e-Drug3D 1065 |
FOSFOMYCIN
|
cas 23155-02-4 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
NATURAL MOLECULE (link) | PK parameters F 37 PERCENT Solubility SOLUBLE IN WATER |
Target TARGET ENOLPYRUVYL TRANSFERASE PDB Ligand code = FCN (link to the list of PDB complexes) Download experimental 3D coordinates of FCN with added hydrogens |
DrugCentral UDP-N-acetylglucosamine 1-carboxyvinyltransferase UNIPROT P0A749 murA |
Download SDF file | [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid Formula: Calculated chemical properties: MW 136.04 NB_atoms 8 XLogP -1.36 PSA 70.418 NB_HD 0 NB_HA 4 fsp3 1.00 Lipinski(0=no;1=yes) 1 |
FDA NDA 050717 (label) INN (FOSFOMYCIN TROMETHAMINE) MONUROL (ZAMBON SPA) APPROVAL= AP YEAR= 1996 NEWMOLECULARENTITY DISCONTINUED NDA 212548 (pdf not found) INN (FOSFOMYCIN TROMETHAMINE) FOSFOMYCIN TROMETHAMINE (XIROMED) APPROVAL= AP YEAR= 2020 NDA 214554 (pdf not found) INN (FOSFOMYCIN TROMETHAMINE) FOSFOMYCIN TROMETHAMINE (ALKEM LABS LTD) APPROVAL= AP YEAR= 2021 NDA 211881 (pdf not found) INN (FOSFOMYCIN TROMETHAMINE) FOSFOMYCIN TROMETHAMINE (CIPLA) APPROVAL= AP YEAR= 2022 NDA 216600 (pdf not found) INN (FOSFOMYCIN TROMETHAMINE) FOSFOMYCIN TROMETHAMINE (AMNEAL) APPROVAL= AP YEAR= 2024 NDA 217187 (pdf not found) INN (FOSFOMYCIN TROMETHAMINE) FOSFOMYCIN TROMETHAMINE (PRECISION DOSE INC) APPROVAL= AP YEAR= 2025 |
Other links: |